Microsoft AI boss and Google DeepMind co-founder Mustafa Suleyman recruited new tech talent to work for Microsoft in Zurich.

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

Hearing the professors’ descriptions, Wu laughs. “I would use a different word. I call it persistence when you feel your ...

The distinction between AI adoption and business transformation is critical. Early adoption often focuses on augmenting ...

Researchers have used AI to find adalimumab effective for iMCD, highlighting the potential of machine learning in discovering ...

Explore how IBM’s approach to AI development differs from its competitors. Learn why the company is winning the enterprise AI ...

Explore the latest tech innovations, from AI and quantum computing to 5G and space travel. Stay updated with News Junction ...

Open data initiatives like Common Crawl and LAION are essential for training generative AI systems. The LAION-5B dataset ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

The need for new fast classification methods has become increasingly important. When a patient arrives at a medical center ...